SCHEMBL2457057

SCHEMBL2457057

CC(C)(C)N1CCN(c2ccc(NC(=O)c3ccc(N)cc3)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.59
USP2 O75604 3/20 0.59
TP53 P04637 2/20 0.59
MAPK1 P28482 2/20 0.59
HSD17B10 Q99714 1/20 0.59
LMNA P02545 4/20 0.58
RAB9A P51151 8/20 0.57
NPC1 O15118 7/20 0.57
KMT2A Q03164 5/20 0.56
MEN1 O00255 3/20 0.56
MCL1 Q07820 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
KDM4E B2RXH2 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
PKM P14618 2/20 0.56
POLB P06746 1/20 0.56
APEX1 P27695 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
ALDH1A1 P00352 4/20 0.55
CYP2C9 P11712 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2453800 0.88 MAPT (0.60) MAPTUSP2TP53MAPK1HSD17B10
SCHEMBL2454605 0.85 MAPT (0.68) MAPTUSP2TP53MAPK1HSD17B10
SCHEMBL27713986 0.84 MAPT (0.54) MAPTUSP2TP53MAPK1HSD17B10
SCHEMBL2458222 0.82 MAPT (0.62) MAPTUSP2TP53MAPK1HSD17B10
SCHEMBL5183437 0.82 NPC1 (0.62) MAPTUSP2TP53MAPK1HSD17B10
SCHEMBL4414247 0.81 HDAC8 (0.77) MAPTTP53MAPK1LMNARAB9A
SCHEMBL20456242 0.81 CTSL (0.51) MAPTUSP2TP53MAPK1HSD17B10
SCHEMBL1476346 0.80 MAPT (0.62) MAPTUSP2TP53MAPK1HSD17B10
SCHEMBL1663341 0.78 HDAC8 (0.71) MAPTTP53MAPK1LMNARAB9A
SCHEMBL18745963 0.78 HDAC8 (0.71) MAPTTP53MAPK1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012982-B2 Modulators of HCV replication ISTITUTO DI RICERCHE BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-09-06 US disclosed
US-20090069344-A1 Modulators of hcv replication ISTITUTO DI RICERCHE BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069344-A1 Modulators of hcv replication EIF2AK2, IRF3, IFNAR1 MAPT 4662/4885USP2 2202/4885TP53 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.